Jessica Dal Col Selected Research

Jessica Dal Col Research Topics

Disease

14	Neoplasms (Cancer) 12/2023 - 10/2007
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 01/2005
4	Lymphoma (Lymphomas) 08/2022 - 05/2008
3	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 01/2020
2	Inflammation (Inflammations) 01/2023 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2020 - 11/2012
2	Epstein-Barr Virus Infections 09/2015 - 08/2007
2	Infections 04/2013 - 10/2007
2	Latent Infection 10/2008 - 08/2007
1	Lung Neoplasms (Lung Cancer) 12/2023
1	Breast Neoplasms (Breast Cancer) 08/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2022
1	Asthma (Bronchial Asthma) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Nasopharyngeal Carcinoma 01/2016
1	Carcinogenesis 02/2014
1	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2005

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 12/2023 - 01/2016
4	VaccinesIBA 12/2023 - 02/2018
4	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2014 - 08/2007
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2015
3	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2020
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2022 - 01/2005
3	Viral ProteinsIBA 12/2013 - 08/2007
2	Phospholipid Transfer ProteinsIBA 12/2023 - 07/2016
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2023 - 01/2023
2	CytokinesIBA 01/2023 - 02/2018
2	Interferon-alpha (Interferon Alfa)IBA 08/2022 - 04/2012
2	MicroRNAs (MicroRNA)IBA 08/2022 - 05/2021
2	Messenger RNA (mRNA)IBA 08/2022 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 02/2018 - 11/2012
2	Antiviral Agents (Antivirals)IBA 02/2014 - 04/2013
1	InterferonsIBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	Alitretinoin FDA Link 12/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	SmokeIBA 01/2023
1	ProteomeIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2022
1	HLA-DR Antigens (HLA-DR)IBA 08/2022
1	CarcinogensIBA 05/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Histocompatibility Antigens Class IIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	CalreticulinIBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 09/2015
1	Viral AntigensIBA 12/2013
1	Small Interfering RNA (siRNA)IBA 04/2013
1	ProdrugsIBA 04/2013
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2012
1	LigandsIBA 11/2012
1	CalcineurinIBA 11/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2012
1	Cyclin D1IBA 09/2008
1	Glycogen Synthase Kinase 3 betaIBA 09/2008
1	Interleukin-12 (IL 12)IBA 10/2007
1	InterleukinsIBA 10/2007
1	Interferon-gamma (Interferon, gamma)IBA 10/2007
1	MonokinesIBA 10/2007
1	Interleukin-4 (Interleukin 4)IBA 01/2005

Therapy/Procedure

6	Immunotherapy 05/2021 - 01/2016
4	Therapeutics 07/2016 - 01/2005